Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Accounts Payables (2022 - 2025)

Core Laboratories (CLB) has 4 years of Accounts Payables data on record, last reported at $36.9 million in Q3 2025.

  • For Q3 2025, Accounts Payables rose 9.87% year-over-year to $36.9 million; the TTM value through Sep 2025 reached $36.9 million, up 9.87%, while the annual FY2024 figure was $34.5 million, 3.11% up from the prior year.
  • Accounts Payables reached $36.9 million in Q3 2025 per CLB's latest filing, down from $41.7 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $45.8 million in Q4 2022 and bottomed at $32.5 million in Q1 2024.
  • Average Accounts Payables over 4 years is $37.0 million, with a median of $36.9 million recorded in 2024.
  • Peak YoY movement for Accounts Payables: dropped 26.92% in 2023, then grew 18.5% in 2025.
  • A 4-year view of Accounts Payables shows it stood at $45.8 million in 2022, then decreased by 26.92% to $33.5 million in 2023, then increased by 3.11% to $34.5 million in 2024, then grew by 6.94% to $36.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $36.9 million in Q3 2025, $41.7 million in Q2 2025, and $38.5 million in Q1 2025.